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Abstract
Background: Hemoglobin vesicles (HbV) are hemoglobin-based oxygen carriers manufactured by liposome
encapsulation of hemoglobin molecules. We hypothesised that the infusion of oxygenated HbV could prolong the
time to circulatory collapse during apnea in rats.
Methods: Twenty-four Sprague-Dawley rats were randomly divided into four groups (Air, Oxy, NS and HbV). The rats
were anaesthetized with isoflurane and the trachea was intubated using 14-gauge intravenous catheters. Rats in the
Air group were mechanically ventilated with 1.5% isoflurane in room air, and those in other groups received 1.5%
isoflurane in 100% oxygen. Mechanical ventilation was withdrawn 1 min after the administration of rocuronium
bromide to induce apnea. After 30 s, 6 mL saline and HbV boluses were infused at a rate of 0.1 mL/s in the NS
and HbV groups, respectively. Circulatory collapse was defined as a pulse pressure < 20 mmHg and the time to
reach this point (PP20) was compared between the groups. The results were analysed via a one-way analysis of
variance and post-hoc Holm–Sidak test.
Results: PP20 times were 30.4 ± 4.2 s, 67.5 ± 9.7 s, 95 ± 17.3 s and 135 ± 38.2 s for the Air (ventilated in room air
with no fluid bolus), Oxy (ventilated with 100% oxygen with no fluid bolus), NS (ventilated with 100% oxygen
with a normal saline bolus), and HbV (ventilated in 100% oxygen with an HbV bolus) groups, respectively, and
differed significantly between the four groups (P = 0.0001). The PP20 times in the HbV group were significantly
greater than in the Air (P = 0.0001), Oxy (P = 0.007) and NS (P = 0.04) groups.
Conclusion: Infusion of oxygenated HbV prolongs the time to circulatory collapse during apnea in rats.
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Background
The situation ‘cannot ventilate, cannot intubate (CVCI)’
during the induction of anaesthesia is one of the most
serious complications anaesthesiologists can encounter.
In some cases, supraglottic airway devices may help to
maintain oxygenation, but otherwise, the reinitiation of
spontaneous ventilation by waking the patient, or the
initiation of emergency intubation pathways, should be
considered [1]. Even after the introduction of fast-acting
drugs and Sugammadex, the time required for the rees-
tablishment of spontaneous breathing is often longer
than expected [2]. Emergency intubation pathways com-
monly involve invasive airway access that require at least
a few minutes of preparation. These techniques are also
highly invasive, and each carries a substantial risk of
technical complications [3].
Hemoglobin vesicles (HbV) are a type of cellular Hb-
based oxygen carrier (HBOC) manufactured by the en-
capsulation of a purified, concentrated Hb solution using
liposomes [4]. Moreover, HbV was developed as an alter-
native to red blood cell (RBC) transfusion and has exhib-
ited efficacy as components of the resuscitative fluid
used to treat haemorrhagic shock in emergency situa-
tions using animal models [5, 6]. The absence of a blood
type antigen and infectious viruses, the small particle
size required for penetration via constricted vessels
through which red blood cells cannot penetrate, and the
stability for long-term storage at room temperature are
also important advantages of HbV [7]. In practice, HbV
is stored in a deoxygenated state, but is rapidly oxygenated
and administered within extremely short time periods.
* Correspondence: schneider.yusuke@gmail.com
1Department of Anesthesiology, Nara Medical University, 840 Shijo-cho,
Kashihara, Nara 634-8522, Japan
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Naito et al. BMC Anesthesiology  (2017) 17:44 
DOI 10.1186/s12871-017-0338-y
Therefore, we hypothesised that the infusion of oxy-
genated HbV could maintain oxygenation in critical sit-
uations (e.g. CVCI) after the induction of anaesthesia.
Accordingly, we tested whether the administration of
HbV could prolong the time to circulatory collapse
during apnea in a rat model.
Methods
All experiments were conducted using 24 male Sprague-
Dawley rats (300–330 g, 10 weeks old). All animals were
purchased from SLC Inc., Shizuoka, Japan. The animals
were housed on a bed of cellulose paper in a ventilated,
temperature controlled, specific-pathogen-free environ-
ment with a 12-h light-dark cycle. The animals were
provided with access to food and water ad libitum. All
experimental protocols were reviewed by the Committee
on the Ethics of Animal Experiments at our University
and were conducted in accordance with the Guidelines
for Animal Experiments issued by the Nara Medical
University and with law no. 105 (Act on Welfare and
Management of Animals) issued by the Japanese govern-
ment. The ethical guidelines conformed to the guiding
principles issued by the National Academy of Science.
Pilot study to define circulatory collapse
To perform a thorough investigation, we first sought to
define the criteria for circulatory collapse. There are pre-
vious reports of apnea in rat models; however, there is
no consensus on the definition of circulatory collapse in
these reports [8, 9]. Moreover, a number of previous
studies have used the mean arterial pressure or systolic
blood pressure to define circulatory collapse [10, 11];
however, these criteria were not used in the present
study as volume infusions lead to a 30% increase in the
total blood volume of the rats, likely resulting in an in-
creased mean arterial and systolic blood pressure. In-
stead, we used the pulse pressure to define circulatory
collapse in our study. We assessed a range of pulse pres-
sures (5, 10, 15, 20 and 25 mmHg) as surrogates of cir-
culatory collapse. The same equipment and drugs
described in the experimental methodology were used in
this pilot study. In brief, five rats were orally intubated
after the induction of anaesthesia via the inhalation of
5% isoflurane in 100% oxygen. The trachea of the rats
was then intubated using 14-gauge intravenous cathe-
ters. Mechanical ventilation was initiated with 1.5% iso-
flurane in room air at 1 L/min and oxygen at 1 L/min to
maintain an FIO2 of 0.6. Adequate anaesthesia was con-
firmed by the absence of the pedal withdrawal reflex in
response to tail pinching. Polyethylene catheters were in-
troduced into the tail arteries to monitor the arterial
blood pressure. Polyethylene catheters were also intro-
duced into the external right jugular vein for the pur-
pose of drug administration. Apnea was induced by the
administration of 1 mg of rocuronium bromide to
inhibit spontaneous breathing followed by extubation.
The apnea times for the pulse pressures of 5, 10, 15, 20
and 25 mmHg were recorded. The mean arterial and
systolic blood pressures were also recorded for a com-
parison with the pulse pressure. Coefficients of variation
(CV, standard deviation divided by the mean value) were
calculated. The pulse pressure with the lowest CV was
defined as a circulatory collapse.
Preparation of HbV
HbV was prepared under sterile conditions, according to
previously reported methods with only slight modifica-
tions [12]. Hemogloin (Hb) was purified from outdated
donated human blood provided by the Japanese Red
Cross Society (Tokyo, Japan). First, Hb was stabilised
using carbonylation (HbCO) and pasteurized (60 °C for
12 h) to inactivate any viruses. All unstable enzymes are
also eliminated by this procedure. The obtained Hb
solution was concentrated by ultrafiltration to 42 g/dL.
Subsequently, pyridoxal 5’-phosphate (PLP; Sigma
Chemical Co., St. Louis, MO) was added to the HbCO
solution as an allosteric effector at a molar ratio of PLP/
Hb tetramer = 1. The Hb solution with PLP was then
mixed with lipids and encapsulated in vesicles. The lipid
bilayer comprised 1,2-dipalmitoyl-sn-glycero-3-phos-
phatidylcholine, cholesterol, 1,5-O-dihexadecyl-N-succi-
nyl-L-glutamate (Nippon Fine Chemical Co. Ltd., Osaka,
Japan) and 1,2-distearoyl-sn-glycerol-3-phosphatidyleth-
anolamine-N-PEG5000 (NOF Corp., Tokyo, Japan) at a
molar ratio of 5:4:0.9:0.03, respectively. The encapsulated
HbCO was converted to HbO2 by exposing the liquid
membranes of HbV to visible light under an O2 atmos-
phere. HbV was dialysed in normal saline to adjust the
Hb concentration to 10 g/dL. Finally, the preparation
was completely deoxygenated for long-term storage. The
physiochemical parameters of HbV are as follows; P50,
17 - 23 mmHg; 251 ± 81 nm particle diameter; and less
than 10% metHb content. Immediately before adminis-
tration, deoxygenated HbV was drawn into a 10-mL
syringe (Terumo Co., Tokyo, Japan) and rapidly oxy-
genated by mixing with air.
Main experimental design
A schematic of the experimental design is shown in
Fig. 1. Before the experiment, the rats were randomised
into four groups (Air, Oxy, NS and HbV groups) and
anaesthetised via the inhalation of 5% isoflurane (Mylan
Inc. PA, USA) in 100% oxygen inside a plastic chamber.
Once unconscious, tracheal intubation was performed
using a 14-gauge intravenous catheter via direct laryn-
goscopy. The rats in the Air group were mechanically
ventilated with 1.5% isoflurane in room air, while the
rats in the other groups were ventilated with 1.5%
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isoflurane in 100% oxygen. All mechanical ventilation was
performed using a small animal ventilator (Harvard Model
683, HARVARD APPARATUS, MA, USA). The respira-
tory rate was set to maintain pCO2 at 35–45 mmHg. The
typical ventilator rates ranged between 55 and 65 breaths/
min with a tidal volume of 8 mL/kg. The adequate anaes-
thesia depth was confirmed as described in the pilot study.
Polyethylene catheters (SP45) filled with heparinised nor-
mal saline were inserted into the tail arteries to measure
the arterial pressure. Polyethylene catheters filled with
heparinised normal saline (SP55) were introduced via the
right jugular vein into the right atrium for the purpose of
drug infusion. Both types of polyethylene catheters were
purchased from Natsume Seisakusho Co. Ltd. Tokyo,
Japan. The blood pressure and pulse rate were monitored
using a continuous monitoring system (PROPAQ 204 EL;
Welch Allyn. NY, USA). The rectal temperature was
maintained between 36.0 °C and 37.5 °C with the aid of
thermal lighting during experiments. The baseline (3 min
before insult) arterial blood analysis was performed (GEM
Premiere 3000; Instrumental Laboratory, MA, USA)
following the administration of 300 units of heparin to
ensure that all values were within the normal range.
Induction of apnea
A total dose of 1 mg rocuronium bromide (MSD. Inc.,
Tokyo, Japan) was administered while the animals were
still under anaesthesia. The tracheal tubes were then
removed and mechanical ventilation was withdrawn to
establish apnea. The animals were visually observed to
ensure that spontaneous breathing did not recover during
the experiments. In addition, the rats in the Air and Oxy
groups did not receive a fluid infusion during apnea. After
a 30-s interval following ventilation withdrawal, the rats in
NS and HbV groups received infusions of 6 mL normal
saline or HbV, respectively, at a rate of 0.1 mL/s. The
blood pressure and pulse rate were continuously recorded
following the withdrawal of mechanical ventilation using a
monitor display and video camera (iPad mini; Apple Inc.,
CA, USA). We defined a circulatory collapse as a pulse
pressure less than 20 mmHg according to our preliminary
study. The time to a pulse pressure less than 20 mmHg
(PP20) was compared between the groups as the primary
study outcome. Video recording was continued until the
pulse pressure fell below 10 mmHg or until 180 s had ex-
pired. After the experiment, all rats were euthanised by an
intravenous administration of 4 mEq potassium chloride.
Randomisation and blinding of the experiment
The animals were randomly assigned to four groups
before the induction of apnea. Randomisation was per-
formed using a computer-generated randomisation table.
The investigators who performed the experiments were
not blinded since it was easy to distinguish which fluid
was administered. The video recordings were investigated
by a researcher who was blinded to the animal groups.
Statistical analyses
Fully saturated Hemoglobin vesicles contain approxi-
mately 0.8 mL oxygen in a 6-mL solution according to the
formula: Oxygen Content = 1.34 * [Hb] * [SaO2] = 1.34 *
10* 1.00. The oxygen consumption of adult rats is
reported to be 0.68 mL/g/h (0.056 mL/s) [13]. We con-
sidered half of the time derived from the calculation
(8 s) to be clinically significant (between group vari-
ance = 64). The within group variance calculated from
the pilot study was 55.
A power analysis demonstrated that a group size of n = 5
was necessary to detect a difference in the mean PP20
values between the groups assuming a statistical power of
0.8 at a significance level of 0.05. We included six rats in
each group to mitigate any loss due to accidental death or
circulatory collapse during the study.
Means ± standard deviation are reported for all mea-
surements unless otherwise specified. All of the data sets
were analysed using Statflex software (Artech Inc., Tokyo,
Japan). To reduce multiple comparisons, differences in the
haemodynamic changes during apnea were compared at
three time points (30, 90 and 150 s) by a repeated measure
ANOVA followed by the Holm–Sidak test. Thirty seconds
following the establishment of apnea was selected as the
first time point as the fluid infusions were initiated at this
time. As the fluids were infused for a duration of 60 s, the
Fig. 1 Outline of the experiment protocol. After the administration
of rocuronium bromide, the mechanical ventilation was withdrawn
to establish apnea. The apnea time to a pulse pressure less than
20 mmHg was compared between the groups
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next time point used was 90 s, and a further time point at
150 s was chosen to maintain consistent intervals. Differ-
ences in the PP20 between each of the groups were ana-
lysed by a one-way ANOVA followed by the Holm–Sidak
test. Since PP20 is a time-to-event variable, we also plotted
it as a Kaplan-Meier curve with a log-rank analysis. The P
values correspond to two-tailed tests with statistical sig-
nificance set at P < 0.05.
Results
Pilot study to define circulatory collapse
The results of the ‘Pilot study to define circulatory
collapse’ are presented in Table 1. We found that the
apnoea time to a pulse pressure lower than 20 mmHg
had the lowest CV value of 0.18. Therefore, we defined a
pulse pressure lower than 20 mmHg as a surrogate out-
come for the circulatory collapse in our main study.
Baseline measurements
The initial body weight, preparation time and blood loss
until apnea demonstrated small standard deviations
within each group and did not differ significantly be-
tween groups. One rat in the Air group was excluded
from the study due to a technical error. Therefore, all
the results shown below are derived from 23 rats (n = 5
for the Air group; n = 6 for all the other groups).
The systolic blood pressure, mean arterial pressure,
pulse pressure and pulse rate measurements at baseline
for each group are shown in Table 2. The rats in the Air
group exhibited a lower systolic blood pressure, mean
arterial pressure and pulse pressure at baseline com-
pared to the other groups. No significant difference in
the systolic blood pressure, mean arterial pressure, or
pulse pressure was observed between the NS, Oxy and
HbV groups. The pulse rate at baseline was similar
between all groups.
The baseline blood analysis was performed prior to
the induction of apnea. Table 3 summarises the baseline
blood analyses. Rats in the Air group had significantly
lower pO2 as they were ventilated with room air while
the other groups were ventilated with 100% oxygen. All
of the other variables were within the normal range with
no differences were observed between groups.
Haemodynamic changes during apnea
The systolic blood pressure, mean arterial pressure and
pulse pressure measurements at 60 s intervals for each
group are shown in Fig. 2. The systolic blood pressure,
mean arterial pressure and pulse pressure was signifi-
cantly lower in the Air group at 30 s compared to the
other groups, while no differences were observed between
the Oxy, NS and HbV groups. At 90 s, the systolic blood
pressure, mean arterial pressure and pulse pressure were
significantly higher in the HbV group compared to all
other groups. At 150 s, the pulse pressure in the HbV






SBP 30 100.6 40.1 0.39
25 113.8 42.1 0.36
20 123.8 38.2 0.30
MAP 20 122.6 39.2 0.31
15 143.8 33.9 0.23
10 192.3 68.6 0.35
PP 25 26.6 7.9 0.29
20 39.4 7.2 0.18
15 46 9.4 0.20
10 68.8 37.9 0.55
5 78.8 41.2 0.52
Data are presented in seconds. A pulse pressure below 20 mmHg had the
lowest CV (Coefficients of variation) and was used to define the circulatory
collapse experimentally. All rats (n = 5) were mechanically ventilated with
room air at 1 L/min and oxygen at 1 L/min to maintain FIO2 = 0.6
SBP systolic blood pressure; MAP mean arterial pressure; PP pulse pressure
Table 2 Haemodynamic variables at baseline
Air Oxy NS HbV
SBP (mmHg) 67.4 (8.1) 99.8 (20.5)a 103.1 (13.7)a 113.1 (13.1)a
MAP (mmHg) 54.8 (5.8) 79.3 (15.9)a 84.5 (11.3)a 92.3 (11.7)a
PP (mmHg) 21.8 (5.1) 28.7 (4.5)a 28.1 (5.7)a 31.8 (4.1)a
PR (beats min−1) 421.6 (14.2) 450.5 (41.3) 410.8 (42.2) 425.0 (58.9)
There was no difference in haemodynamic variables between Oxy, NS and
HbV groups at baseline. astatistically significant difference from the Air group
analysed by one-way ANOVA followed by a Holm-Sidak test (P < 0.01)
SBP systolic blood pressure; MAP mean arterial pressure; PP pulse pressure;
PR pulse rate
Table 3 Baseline arterial blood analysis
Air Oxy NS HbV
pH 7.44 (0.04) 7.46 (0.03) 7.40 (0.09) 7.42 (0.08)
pO2 (mmHg) 73.4 (18.0) 399.1 (37.5)
a 466.3 (53.9)a 433 (86.8)a
pCO2 (mmHg) 37.4 (2.2) 33.3 (3.4) 42.7 (17.1) 40.5 (7.3)
Hct (%) 40 (2.9) 39.5 (3.7) 38 (3.7) 37.8 (1.5)
Hb (g/dL) 12.4 (0.9) 12.5 (1.3) 11.8 (1.2) 11.8 (0.4)
Na (mmol/L) 135.4 (3.4) 134.0 (4.0) 134.3 (4.3) 133.2 (7.0)
K (mmol/L) 4.8 (0.5) 4.2 (0.5) 4.3 (0.8) 4.2 (0.5)
Ca (mmol/L) 1.2 (0.06) 1.2 (0.10) 1.2 (0.16) 1.2 (0.07)
BE (mmol/L) 1.62 (2.1) −0.18 (1.7) 0.25 (2.9) 1.25 (2.4)
Hct haematocrit; Hb hemoglobin concentration (g/dL); BE base
excess (mmol/L)
aStatistically significant difference between the Air group with a one-way
ANOVA followed by a Holm-Sidak test (P < 0.01). Baseline arterial blood analysis
was performed before the withdrawal of mechanical ventilation, and 0.3-mL
arterial blood was collected from the tail artery. All variables except pO2 were
within the normal range
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group was higher compared to the Air group, while there
were no significant differences between the Oxy and NS
groups. However, the systolic blood pressure and mean
arterial pressure in the HbV group were consistently sig-
nificantly higher than the Oxy and NS groups.
Apnea time to a pulse pressure less than 20 mmHg (PP20)
The apnea time to a pulse pressure less than 20 mmHg
(PP20) was compared between the four groups as the pri-
mary outcome of this study. The mean PP20 values ±
standard deviation were 30.4 ± 4.2 s, 67.5 ± 9.7 s, 95 ±
17.3 s and 135 ± 38.2 s for the Air, Oxy, NS and HbV
groups, respectively. The mean PP20 values for all groups
significantly differed from every other group by a one-
way ANOVA followed by Holm-Sidak test (Air vs. Oxy
P = 0.0001; Air vs. NS P = 0.0001, Air vs. HbV P = 0.002,
Oxy vs. NS P = 0.002, Oxy vs. HbV P = 0.007 and NS vs.
HbV P = 0.04). The Kaplan-Meier curves for the apnea
time to a pulse pressure less than 20 mmHg are plotted
in Fig. 3. A long rank analysis revealed statistical differ-
ences between the four groups. (Air vs. HbV P = 0.004;
Oxy vs. HbV, P = 0.003; NS vs. HbV, P = 0.045). There
were also similar trends regarding the time to reach
pulse pressures below 15 [see Additional file 1] and
10 mmHg [see Additional file 2] between the groups.
Discussion
To the best of our knowledge, this is the first report to
demonstrate the effect of hemoglobin based oxygen car-
rier (HBOC) therapy during apnea. We found that the
administration of oxygenated HbV more than doubled
the apnea time to circulatory collapse when compared to
the Oxy group.
In 1949, Amberson reported the first case series of
clinical experiences using an Hb-saline solution [14].
Although it was effective for the delivery of oxygen, the
Fig. 2 Haemodynamic changes after the withdrawal of mechanical
ventilation. Systolic blood pressure (a), mean arterial pressure (b) and
pulse pressure (c) for each group are shown. The rats in the Air group
were ventilated with room air while the other groups were ventilated
with 100% oxygen. The NS group were infused with 6 mL normal
saline and the HbV group was infused with 6 mL HbV. The arrows
indicate periods of fluid infusion. The differences between the groups
were analysed by a one-way repeated measure ANOVA followed by a
Holm-Sidak test. SBP, systolic blood pressure; MAP, mean arterial
pressure; PP, pulse pressure. Symbols represent significant differences.
*: P < 0.05; ** P < 0.01; *** P < 0.001
Fig. 3 A Kaplan-Meier curve for the apnea time to a pulse pressure
less than 20 mmHg for each group. There was a statistically significant
difference between the groups assessed by a log-rank test (Air vs. HbV
P = 0.004; Oxy vs. HbV, P = 0.003; NS vs. HbV, P = 0.045)
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Hb-saline solution was found to be associated with high
renal toxicity and vasopressive reactions; therefore, its
use was discontinued. Subsequently, a large variety of
modified HBOCs have been developed in an attempt to
overcome these complications. These include cross-linked
polyHb, conjugated Hb, cross-linked tetrameric Hb, re-
combinant human Hb, and HbV [10, 11, 15–17]. A num-
ber of these modified HBOCs have also been used to treat
anaemic patients for whom a blood transfusion is not
readily available [18]. However, other reports have indi-
cated that these products are still associated with sig-
nificant toxic properties that have been attributed to
myocardial infarction, acute renal failure, a deleterious
increase in arterial blood pressure, and death [19, 20].
Such complications resulting from the use of HBOCs
are thought to be mediated by the direct interaction be-
tween molecular Hb and the blood or endothelial cells;
thus, preventing this direct contact via the encapsulation of
Hb may lessen these complications. Previous studies have
demonstrated that HbV does not exhibit renal toxicity or
cause vasoconstriction [21]. Therefore, we can safely affirm
that the haemodynamic difference observed in our study
were not attributed to vasoconstriction.
Theoretically, an infusion of 6 mL HbV will prolong the
apnea time to circulatory collapse by 15 s. To our surprise,
the mean difference between the Oxy and the HbV groups
was found to be 67.5 s. This discrepancy may be explained
by the results from the NS group. The NS group was
included to assess the effect of the infusion volume since
HbV does not have collioid osmotic pressure. We pre-
dicted that an infusion greater than 30% of the total circu-
lating volume would lead to acute heart failure, shortening
the PP20 in the NS group. However, the PP20 in the NS
group was higher than that of the Oxy group. One reason
for this might be the blood viscosity. Infusing normal sa-
line causes haemodilution, resulting in a better cardiac
contraction in the NS and HbV groups. Recently, it has
been demonstrated that a saline infusion, while increasing
the left ventricular end diastolic volume, also decreases
the left ventricular end systolic volume resulting in in-
creased cardiac contraction [22]. Although the administra-
tion of normal saline may have an impact on the time to
circulatory collapse, any negative effects (e.g. high chloride
acidosis or hypernatremia) should be noted. Another pos-
sible explanation involves a higher level of effective oxygen
transport by HbV than RBCs to the myocardium, as it has
a high oxygen consumption and steep oxygen tension gra-
dient. Since HbV is smaller than RBCs, it is distributed
closer to the endothelial cell layer during arteriolar blood
flow, whereas RBCs flow closer to the axial line [23].
Biochemical data (e.g. base excess or lactate levels) may
have been informative and supported our analyses; how-
ever, blood samples from the tail artery during circulatory
collapse were not obtained.
We used the pulse pressure to define circulatory
collapse in our study. The apnea time to reach a pulse
pressure less than 20 mmHg had the lowest coefficient
of variation (CV); a low CV value indicates high repro-
ducibility. Although the pulse pressure at baseline in our
results was close to 20 mmHg, all of the animals exhibited
an increased pulse pressure and systolic blood pressure,
reflecting a hyper haemodyanamic state following apnoea.
Moreover, this phenomenon is consistantly observed in
this model [9], indicating that the actual pulse pressure
decreased from a higher value (i.e. 40 mmHg). Finally, we
chose a pulse pressure less than 20 mmHg as an out-
come of this study based on our predefined protocol;
however, there were also similar trends regarding the
time to reach pulse pressures below 15 and 10 mmHg
between the groups.
Finally, the infusion of oxygenated hemoglobin (artifi-
cial or not) will increase the total amount of oxygen in
the body. Therefore, our experimental results are natural
in most part. However, HbV is an artificial RBC, which
can be stored at room temperature for more than 2 years.
Moreover, the time required for the oxygenation of HbV
in our experiment was within 5 s. During critical hyp-
oxic situations (e.g. CVCI), the time required for the
preparation of the drug would be essential.
Limitations
Although all experiments were performed as thoroughly
as possible, there are some limitations to this study.
Firstly, we used the tail arteries to monitor any haemo-
dynamic changes. As the tail artery is a small peripheral
artery, the pulse pressure may be affected more by fac-
tors, such as blood pressure, blood volume and cardiac
contractility. Thus, it may not be entirely reflective of
the central haemodynamics, especially when the rats
were in a state of near circulatory collapse. We have
added one additional experiment to overcome this limi-
tation, in which we monitored the pulse pressure in the
tail artery and left common carotid artery consecutively.
We found a strong relationship between the pulse pres-
sures; however, they deviated greatly after the pulse pres-
sure in the tail artery dropped lower than 25 mmHg.
This may account for the finding that the CV was the
lowest for 20 mmHg but increased for the lower pulse
pressures. In addition, the femoral artery or descending
aorta may have more accurately assessed the central cir-
culation in this study.
Secondly, our results may have been confounded by
the significantly lower haemodynamic variables in the
Air group compared to other groups at baseline. How-
ever, we do not believe this to be a serious limitation of
our study as we successfully achieved the main endpoint
by demonstrating that the HbV group exhibited a
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prolonged time to collapse compared to the Oxy and NS
groups.
Conclusion
The infusion of HbV during apnoea in rats prolonged
the time to circulatory collapse. The demonstration of
HbV utility in a state of apnoea suggests that HbV may
be efficacious as a bridging therapy in CVCI situations
encountered clinically.
Additional files
Additional file 1: Figure S1. A Kaplan-Meier curve for the apena time
to a pulse pressure less than 15 mmHg for each group is shown. The
PP15 times were 31.2 ± 5.1 s, 78.8 ± 21.0 s, 121 ± 53.8 s and 155 ± 44.4 s
for the Air, Oxy, NS and HbV groups, respectively. Log-rank test revealed
statistical difference between HbV and Air (P= 0.006), HbV and Oxy (P= 0.003)
but did not differ between HbV and NS (P= 0.04). (PNG 133 kb)
Additional file 2: Figure S2. A Kaplan-Meier curve for the apena time
to a pulse pressure less than 10 mmHg for each group is shown. The
PP10 times were 58.8 ± 35.8 s, 136 ± 52.6 s, 155 ± 68.8 s and 190 ± 32.9 s
for the Air, Oxy, NS and HbV groups, respectively. Log-rank test revealed
statistical difference between HbV and Air (P = 0.006), HbV and Oxy (P= 0.04)
but did not differ between HbV and NS (P = 0.82). (PNG 116 kb)
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